Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus-Reference-Cited by-同舟云学术

Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus

Published:2015-04 Issue:4 Volume:87 Page:828-838
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Gallon Lorenzo,Traitanon Opas,Sustento-Reodica Nedjema,Leventhal Joseph,Javeed Ansari M.,Gehrau Ricardo C.,Ariyamuthu Venkatesh,De Serres Sacha A.,Alvarado Antonio,Chhabra Darshika,Mathew James M.,Najafian Nader,Mas Valeria

Publisher

Elsevier BV

Subject

Nephrology

Reference39 articles.

1. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era;Meier-Kriesche;Am J Transpl,2004

2. Optimal immunosuppression to prevent chronic allograft dysfunction;Grinyo;Kidney Int Suppl,2010

3. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus;Chhabra;Clin J Am Soc Nephrol,2012

4. Therapeutic targets in the treatment of allograft fibrosis;Mannon;Am J Transpl,2006

5. The Banff 97 working classification of renal allograft pathology;Racusen;Kidney Int,1999

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tristetraprolin mediates immune evasion of mycobacterial infection in macrophages;FASEB BioAdvances;2024-06-29

2. Overcoming barriers to widespread use of CAR‐Treg therapy in organ transplant recipients;HLA;2022-03-06

3. mTOR‐dependent immunometabolism as Achilles' heel of anticancer therapy;European Journal of Immunology;2021-11-14

4. Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD;Frontiers in Immunology;2021-10-11

5. Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy;Epilepsy Research;2020-03